Gardasil Label Expansion To Women 27-45 Delayed Until 2010, At The Earliest
Merck receives a second “complete response” letter from FDA related to its sBLA to extend indications for the vaccine to older women.
Merck receives a second “complete response” letter from FDA related to its sBLA to extend indications for the vaccine to older women.